PTEN and lung carcinoma: Based on the knowledge that persistent hypoxia-induced aberrant signaling pathway should be therapeutic target for lung cancer [18, 19], we aimed to determine that persistent hypoxia can modulate the PTEN activity in lung cancers and that unphosphorylated PTEN can inhibit hypoxia-induced EMT.